Artificial Urinary Sphincter Market: Development in R&D activities will drive Sector Growth

The global artificial urinary sphincter market is expected to be worth US$ 441.7 million in 2022, rising at a 5.2% CAGR to be worth US$ 769.2 million by 2032. The rising use of lactic acid in end-user industries is related to growth. The lactic acid market grew at a 4.5% CAGR between 2016 and 2021.

Urinary sphincters are two muscles that govern the passage of urine via the urethra in the urinary bladder. These muscles are essential for urine retention and release. These two muscles are known as the external and internal urethral sphincters. When one of the muscles contracts, the urethra closes, preventing urine passage.

The artificial urine sphincter market is primarily driven by a few key reasons, including patients' strong reliance on time-tested goods, increasing breakthroughs in the artificial urinary sphincter, new product releases, and patient demand for safe and effective solutions. In addition, the artificial urinary sphincter market is experiencing considerable expansion as a result of rising healthcare expenditure in emerging countries.

The global ageing population and the rising incidence of urine incontinence are driving the artificial urinary sphincter market. The rising frequency of prostate procedures in males causes urine incontinence, which is one of the driving forces in the artificial urinary sphincter industry.

Key Players:

  • Boston Scientific Corporation
  • RBM - Reinhard Becker Medizinprodukte
  • ZSI
  • Zephyr Surgical Implants
  • Silimed Medical Devices
  • Albyn Medical
  • GT Urological LLC
  • Promedon
  • UroMems Inc.
  • Uromedica Inc.
  • My powers Medical
  • CooperSurgical Inc.
  • Laborie Medical Technologies Inc

Get More Insights@ https://www.futuremarketinsights.com/reports/artificial-urinary-sphincter-market

On the basis of end user, the global Artificial Urinary Sphincter market study contains:

  • Hospitals
  • Clinics
  • Academic and Research Institutes

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more